MG
AMTI

Michael Gelband’s Applied Molecular Transport Inc. Common Stock AMTI Stock Holding History

Michael Gelband’s Portfolio AMTI Stock Details AMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-60,033
Closed -$839K – 2792
2021
Q4 		$839K Buy
+60,033
New +$1.18M 0.01% 1164

Other funds holding AMTI

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
FFVM
Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FFVM
Founders Fund VI Management San Francisco, California $45.8K AUM 58.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Michael Gelband's AMTI Position: Q1 2022 in Review

Michael Gelband sold out of Applied Molecular Transport Inc. Common Stock (AMTI) in Q1 2022, closing a stake of 60,033 shares — an estimated $839K sold.

Michael Gelband first reported a position in AMTI in Q4 2021 and held it in 1 quarter. The position peaked at $839K in Q4 2021. 77 funds tracked by Wall St. Rank hold AMTI as of Q1 2022.

  • Michael Gelband reported no remaining Applied Molecular Transport Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Michael Gelband sold 60,033 Applied Molecular Transport Inc. Common Stock shares in Q1 2022, an estimated $839K.
  • Michael Gelband first reported a position in Applied Molecular Transport Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Michael Gelband's Applied Molecular Transport Inc. Common Stock position peaked at $839K in Q4 2021.
  • 77 funds tracked by Wall St. Rank held Applied Molecular Transport Inc. Common Stock as of Q1 2022.

Based on ExodusPoint Capital Management's 13F filing for Q1 2022, filed 13 May 2022.